| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |